<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIM: The present study was designed to analyse clinical, haematological and histomorphogical features in 37 cases of myelodysplasic syndrome (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>MATERIAL AND METHODS: FAB criteria was used to diagnose <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> in 37 patients </plain></SENT>
<SENT sid="2" pm="."><plain>Clinical details, peripheral blood findings, bone marrow aspirate and biopsy were reviewed </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: Of 37 cases, there were 25 females and 12 males in age range of 2 years to 75 years </plain></SENT>
<SENT sid="4" pm="."><plain>There were three children </plain></SENT>
<SENT sid="5" pm="."><plain>There were nine cases of refractory <z:hpo ids='HP_0001903'>anaemia</z:hpo> (RA), 18 of refractory <z:hpo ids='HP_0001903'>anaemia</z:hpo> with excess blasts (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e>), nine of refractory <z:hpo ids='HP_0001903'>anaemia</z:hpo> with excess blasts in transformation (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e>-t) and one of <z:hpo ids='HP_0011010'>chronic</z:hpo> myelomonocytic <z:hpo ids='HP_0001909'>leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CMML</z:e>) </plain></SENT>
<SENT sid="6" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> were denovo <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients had <z:hpo ids='HP_0000980'>pallor</z:hpo> </plain></SENT>
<SENT sid="8" pm="."><plain>Hepato and/or <z:hpo ids='HP_0001744'>splenomegaly</z:hpo> was seen in 15 cases </plain></SENT>
<SENT sid="9" pm="."><plain><z:hpo ids='HP_0001903'>Anemia</z:hpo>, <z:hpo ids='HP_0001882'>leukopenia</z:hpo> and <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo> was seen in 37, 6 and 23 cases respectively </plain></SENT>
<SENT sid="10" pm="."><plain>Bone marrow <z:hpo ids='HP_0002835'>aspiration</z:hpo> (BMA) was hyper to normo cellular in 35 cases </plain></SENT>
<SENT sid="11" pm="."><plain>Dyshemopoiesis was seen in one or more cell lines in <z:hpo ids='HP_0000001'>all</z:hpo> cases </plain></SENT>
<SENT sid="12" pm="."><plain>Bone marrow biopsy (BMB) was available in 16 cases </plain></SENT>
<SENT sid="13" pm="."><plain>Abnormal localisation of immature precursors (ALIP) was seen in 11/12 biopsies of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e> and 3/4 of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e>-t </plain></SENT>
<SENT sid="14" pm="."><plain>BMB was helpful in diagnosis of 3 doubtful cases (one <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e> and two <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e>-t), and upgrading of 2 cases of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e> to <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e>-t </plain></SENT>
<SENT sid="15" pm="."><plain>On follow up, 1 case of RA, 3 of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e>, 1 of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e>-t developed <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> </plain></SENT>
<SENT sid="16" pm="."><plain>One case of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e> developed ALL and 2 progressed to <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e>-t </plain></SENT>
<SENT sid="17" pm="."><plain>CONCLUSION: Primary <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> is seen in <z:hpo ids='HP_0000001'>all</z:hpo> age groups </plain></SENT>
<SENT sid="18" pm="."><plain><z:hpo ids='HP_0000980'>Pallor</z:hpo> is commonest presentation </plain></SENT>
<SENT sid="19" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e> was commonest subgroup seen </plain></SENT>
<SENT sid="20" pm="."><plain>BMB is helpful in diagnosis of doubtful cases </plain></SENT>
<SENT sid="21" pm="."><plain>ALIP is a reliable diagnostic feature of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
<SENT sid="22" pm="."><plain>BMB is a diagnostic as well as prognostic tool in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> cases which should be taken as a mandatory investigation </plain></SENT>
</text></document>